pharmaceutical daily

Rocephin Drug Insight Report 2019 with Sales Forecasting to 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Rocephin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering.

Rocephin – Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with their location.

The report covers the Global Market Assessment of the Rocephin covering the historical global sales and also provides the Rocephin sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Rocephin and emerging therapies in this space.

Scope

Reasons to Buy

Key Topics Covered

1. Report Introduction

2. Rocephin – Overview

3. Product Details

4. Rocephin Sales Assessment

5. Patent Details

6. Global API Manufacturers Assessment

7. Market Competition

8. Emerging Therapies

9. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/defrdi

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version